Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7180146 | 1.00 | CA1 (0.39) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL13213063 | 1.00 | CA1 (0.39) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL6428213 | 0.94 | — | — | |
| SCHEMBL16691800 | 0.94 | — | — | |
| SCHEMBL13767450 | 0.88 | CA1 (0.46) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL1643437 | 0.88 | CA1 (0.39) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL14446407 | 0.88 | CA1 (0.46) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL21757863 | 0.88 | CA1 (0.46) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL7923389 | 0.88 | CA1 (0.46) | CA1CA2CA4ALDH1A1TSHR | |
| SCHEMBL8161261 | 0.88 | CA1 (0.46) | CA1CA2CA4ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0825166-B1 | Methyl substituted hexahydroindanols and perfumery uses thereof | INT FLAVORS & FRAGRANCES INC (US) | 2001-10-31 | — | — | EP | claimed |
| US-5733866-A | Methyl substituted hexahydroindanols and alkyl ethers thereof, organoleptic uses thereof, processes for preparing same and process intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-03-31 | — | — | US | claimed |
| EP-0825166-A2 | Methyl substituted hexahydroindanols and perfumery uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-02-25 | — | — | EP | claimed |
| CN-111704563-A | Trifluorosulfonamide hexahydroindan photoresist resin monomer and preparation method thereof | 徐州博康信息化学品有限公司 | 2020-09-25 | — | — | CN | disclosed |
| EP-3362428-B1 | NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS | INT FLAVORS & FRAGRANCES INC (US) | 2020-05-06 | — | — | EP | disclosed |
| EP-1524255-B1 | Polyalkylbicyclic derivatives | INT FLAVORS & FRAGRANCES INC (US) | 2013-05-01 | — | — | EP | disclosed |
| US-7771919-B2 | High refractive index fluids for immersion lithography | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-10 | — | — | US | disclosed |
| US-7586103-B2 | High refractive index fluids for immersion lithography | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-09-08 | — | — | US | disclosed |
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | QUATRX PHARMACEUTICALS CO. | 2008-07-17 | — | — | US | disclosed |
| US-20080075884-A1 | radiation curing ink cures with high sensitivity to form a high quality, durable image resistant to cracking, peeling and has excellent impact resistance, flexibility, and adhesion; a polymerizable monomer and a polymerization initiator and comprising substantially no colorant | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080063990-A1 | High Refractive Index Fluids for Immersion Lithography | HONEYWELL INTERNATIONAL, INC. (US) | 2008-03-13 | — | — | US | disclosed |
| EP-0825166-A3 | Methyl substituted hexahydroindanols and perfumery uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5733866-A | Methyl substituted hexahydroindanols and alkyl ethers thereof, organoleptic uses thereof, processes for preparing same and process intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-03-31 | — | — | US | disclosed |
| US-5733866-A | Methyl substituted hexahydroindanols and alkyl ethers thereof, organoleptic uses thereof, processes for preparing same and process intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-03-31 | — | — | US | disclosed |
| US-5733866-A | Methyl substituted hexahydroindanols and alkyl ethers thereof, organoleptic uses thereof, processes for preparing same and process intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0824962-A1 | OXIDATION CATALYST SYSTEM AND PROCESS FOR OXIDATION WITH THE SAME | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-25 | — | — | EP | disclosed |
| EP-0825166-A2 | Methyl substituted hexahydroindanols and perfumery uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0825166-A2 | Methyl substituted hexahydroindanols and perfumery uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0825166-A2 | Methyl substituted hexahydroindanols and perfumery uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0189662-B1 | NOVEL DIPHOSPHONATES AND USE THEREOF IN PHARMACEUTICAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | CYP2R1, CYP24A1, VDR | CA1 4295/4885CA2 4407/4885CA4 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.